Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation

BACKGROUND: Trimethoprim-sulfamethoxazole (TMP-SMX) is the drug of choice for anti-Pneumocystis jirovecii pneumonia (PcP) prophylaxis in kidney transplant recipients (KTR). Post-transplant management balances preventing PcP with managing TMP-SMX-related adverse effects. TMP-SMX dose reduction addres...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Infect Dis
Autori principali: Prasad, G. V. Ramesh, Beckley, Jill, Mathur, Mohit, Gunasekaran, Madhushankar, Nash, Michelle M., Rapi, Lindita, Huang, Michael, Zaltzman, Jeffrey S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451305/
https://ncbi.nlm.nih.gov/pubmed/30953458
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-019-3944-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi